Literature DB >> 2480751

Antikeratin autoantibodies in the amyloid deposits of lichen amyloidosus and macular amyloidosis.

K Ito1, K Hashimoto.   

Abstract

In order to characterize immunoglobulins found on amyloid deposits of lichen amyloidosus and macular amyloidosis, and elution from cryostat sections was performed with citrate buffer, glycine buffer, NaCl, and PBS. Resulting eluates (mainly IgG) were examined with dot immunoblotting and SDS-PAGE immunoblotting and were found to react with the human epidermal keratin of 50 and 67 kD. Antikeratin autoantibody activities in normal murine and human sera were examined using a dot immunoblotting assay. In murine sera, titers of IgG and IgM autoantibodies were higher in older mice. The human cord blood showed significantly lower IgM autoantibody titers, whereas IgG antibody titers showed no significant differences from adults' sera, probably due to the permeability of IgG through the placental barrier. A stronger antibody activity in older individuals was thought to be due to the repeated exposures to keratin proteins derived from apoptotic keratinocytes. Sera from lichen amyloidosus and macular amyloidosis patients did not show any difference from normal controls in their antikeratin titers. It was concluded that the patients with lichenoid or macular amyloidosis are capable of producing a normal level of antikeratin autoantibodies. However, the removal of opsonized keratin-type amyloid from the skin is slow or deficient due to as yet unknown factors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2480751     DOI: 10.1007/bf00455320

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  41 in total

1.  Apoptotic keratin bodies as autoantigen causing the production of IgM-anti-keratin intermediate filament autoantibodies.

Authors:  G Grubauer; N Romani; H Kofler; U Stanzl; P Fritsch; H Hintner
Journal:  J Invest Dermatol       Date:  1986-10       Impact factor: 8.551

2.  Immunofluorescent staining of keratin fibers in cultured cells.

Authors:  T T Sun; H Green
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

3.  Immunoglobulins and complement C' 3 in lichen amyloidosus. Immunofluorescent study.

Authors:  S G Stringa; C Bianchi; A Casala; O Bianchi
Journal:  Arch Dermatol       Date:  1972-04

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Epidermal cytoplasmic antibodies: incidence and type in normal persons and patients with melanoma.

Authors:  E A Abel; J C Bystryn
Journal:  J Invest Dermatol       Date:  1976-01       Impact factor: 8.551

6.  Monoclonal antikeratin antibody: production, characterization, and immunohistochemical application.

Authors:  H Eto; K Hashimoto; H Kobayashi; M Matsumoto; T Kanzaki; A H Mehregan; R A Weiss
Journal:  J Invest Dermatol       Date:  1985-05       Impact factor: 8.551

7.  Histogenesis of primary localized cutaneous amyloidosis: sequential change of epidermal keratinocytes to amyloid via filamentous degeneration.

Authors:  M Kumakiri; K Hashimoto
Journal:  J Invest Dermatol       Date:  1979-08       Impact factor: 8.551

8.  Amyloidogenesis in organ-limited cutaneous amyloidosis: an antigenic identity between epidermal keratin and skin amyloid.

Authors:  H Kobayashi; K Hashimoto
Journal:  J Invest Dermatol       Date:  1983-01       Impact factor: 8.551

9.  Phagocytosis of keratin filament aggregates following opsonization with IgG-anti-keratin filament autoantibodies.

Authors:  H Hintner; N Romani; U Stanzl; G Grubauer; P Fritsch; T J Lawley
Journal:  J Invest Dermatol       Date:  1987-02       Impact factor: 8.551

10.  Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes.

Authors:  G Lavie; D Zucker-Franklin; E C Franklin
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.